covaxin india | Zee News

Advertisement

Newscovaxin india

Covaxin india News

COVID-19 vaccine

21 Apr 2021

How many tested COVID positive after first, 2nd dose of vaccine in India?

NITI Aayog Member (Health) V K Paul noted that there is a risk even after taking vaccination "We stress people to follow COVID appropriate behaviour even after taking the vaccination," he said

27 Feb 2021

People with THESE health conditions will get COVID-19 vaccine jabs on priority

In the third phase of the coronavirus vaccination drive which begins from March 1, the government is aiming to expand the vaccination drive to the general public of the nation. People with co-morbid conditions will need to carry a medical certificate to receive the vaccination.

27 Feb 2021

For COVID-19 vaccine in private hospital this is how much you may have to pay

NITI Aayog has promulgated a price range of Rs 300-500 which the private hospitals can charge for the two COVID-19 vaccines. The government has been procuring SII's Covishield for around Rs 210 per dose while the cost of Covaxin is around Rs 290 for a shot.

27 Feb 2021

COVID-19 vaccine price between Rs 300-500, proposes NITI Aayog

The NITI Aayog has promulgated a price range of Rs 300-500 for two Covid vaccines that would be available for the priority group at private facilities. In the third phase of vaccination set to begin from March 1 Covid vaccines will be available in private hospitals as well.

14 Jan 2021

Covaxin only for those above 18 years, not for children: Dr Krishna Ella

The indigenous vaccine is developed and manufactured at Bharat Biotech’s Biosafety Level-3 biocontainment facility. The vaccine is only for those above 18 years, not for children as the research has to be done in the case of covid vaccine for children. Covaxin may be priced near Rs 1,000 when it reaches to the market.

COVID-19 vaccine

24 Dec 2020

Covaxin: AIIMS New Delhi invites volunteers for Phase-III clinical trial

Union Health Minister Harsh Vardhan on December 19 had said that country`s scientists and health experts have worked on the development of an indigenous vaccine In the upcoming six to seven months, India will have the capacity to inoculate about 30 crore people The six vaccine candidates which are in various stages of the clinical trial are - Covishield, Covaxin, ZyCoV-D, Sputnik V, NVX-CoV2373

30 Jun 2020

COVID-19 Vaccine: India’s COVAXIN gets DCGI approval for human clinical trials

The Drug Controller General of India has allowed Bharat Biotech India (BBIL) to conduct human clinical trials for ‘COVAXIN’, a potential COVID-19 vaccine. The human clinical trials will start across India in July 2020. If it emerges successful, COVAXIN will be available by year’s end.

Loading...